COVID-19 mRNA Vaccines Are Generally Safe in the Short Term: A Vaccine Vigilance Real-World Study Says

BACKGROUND: The prophylactic vaccination of COVID-19 mRNA vaccines is the first large-scale application of this kind in the human world. Over 1.8 million doses of the COVID-19 vaccine had been administered in the US until December 2020, and around 0.2% submitted AE reports to the Vaccine Adverse Eve...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Gang, Li, Xiaolin, Sun, Meixing, Zhou, Yangzhong, Yin, Meifang, Zhao, Bin, Li, Xuemei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177815/
https://www.ncbi.nlm.nih.gov/pubmed/34093567
http://dx.doi.org/10.3389/fimmu.2021.669010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177815/
https://www.ncbi.nlm.nih.gov/pubmed/34093567
http://dx.doi.org/10.3389/fimmu.2021.669010

Ejemplares similares